Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. In addition to causing cervical cancer in females, it also causes genital warts and cancers in males. The HPV vaccine has been recently approved for use in males. This literature review explores factors that influence HPV vaccination in males. A systematic review of the CINAHL database and Google scholar and journals published from 2004 to 2011 indicate significant factors that increase vaccination likelihood are increased knowledge and awareness among patients, parents, and providers. Provider ecommendations are a high priority in patient and parent acceptability of vaccine, while rofessional organization endorsement is important for providers. Factors that decrease likelihood include lack of knowledge and questionable cost to benefit ratio. Barriers to HPV vaccination in males include lack of knowledge and awareness, which can be emedied with increased education. Further research is needed to evaluate cost effectiveness as new evidence of vaccine coverage, efficacy, and HPV-related morbidity surface and as recommendations change.
Metrics
Details
Title
Factors Influecing HPV Vaccination in Males
Creators
Charlotte Davis
Contributors
Lorna Schumann (Advisor)
Awarding Institution
Washington State University
Academic Unit
Research Projects, College of Nursing
Theses and Dissertations
Master of Nursing (MN), Washington State University
Publisher
Washington State University; Spokane, Washington
Identifiers
99900590724801842
Copyright
http://creativecommons.org/licenses/by-nc-sa/3.0/us; Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States (CC BY-NC-SA 3.0 US)